Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Kidney & Blood Pressure Research|June 6, 2022
How the Availability of Anti-C5a Agents Could Change the Management of Antineutrophil Cytoplasmic Antibody-Associated VasculitisDario Roccatello, Roberta Fenoglio, Valentina Oddone, et al.Kidney & Blood Pressure Research|September 21, 2023
Antiphospholipid Syndrome and Kidney InvolvementEmanuele De Simone, Savino Sciascia, Roberta Fenoglio, et al.Clinical and Experimental Rheumatology|February 5, 2016
Immunogenetics of complement in mixed cryoglobulinaemiaElisa Menegatti, Margherita Messina, Valentina Oddone, et al.Therapeutic Drug Monitoring|October 1, 2008
An HPLC-PDA method for the simultaneous quantification of the HIV integrase inhibitor raltegravir, the new nonnucleoside reverse transcriptase inhibitor etravirine, and 11 other antiretroviral agents in the plasma of HIV-infected patientsAntonio D'Avolio, Lorena Baietto, Marco Siccardi, et al.American Journal of Nephrology|March 30, 2022
New Onset Biopsy-Proven Nephropathies after COVID VaccinationRoberta Fenoglio, Stefania Lalloni, Martina Marchisio, et al.Journal of Pharmaceutical and Biomedical Analysis|November 13, 2010
A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluationAntonio D'Avolio, Marco Simiele, Marco Siccardi, et al.Diagnostics (Basel, Switzerland)|February 13, 2026
Integrating Anti-Phosphatidylserine/Prothrombin Antibodies Testing into Antiphospholipid Syndrome Diagnostics: A Multidomain, Expert Perception-Based Health Technology AssessmentMichele Cioffi, Valentina Oddone, Massimo Radin, et al.Clinical and Experimental Rheumatology|May 3, 2020
Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19Savino Sciascia, Franco Aprà, Alessandra Baffa, et al.Pageof 1